DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3Dr. Reddy's Laboratories
02 4Alfred E Tiefenbacher GmbH
03 2Breckenridge Pharmaceutical
04 2Bal Pharma
05 2ANGITA PHARMA INC.
06 6Accord healthcare
07 4Apotex Inc
08 2Auro Pharma Inc
09 2Aurobindo Pharma Limited
10 2Austell Laboratories
11 2BIOMED 2002 INC
12 2Bionpharma
13 2Bluepharma
14 4Bristol Laboratories Ltd
15 38Bristol Myers Squibb
16 2Cipla Medpro South Africa
17 2Dr Reddy's Laboratories (Pty) Ltd
18 2Dr Seidel Life Science
19 1Eqova
20 1Evertogen
21 2Farmaprojects S.A.U
22 2Hetero Drugs
23 2INNOVATA PHARMACEUTICALS
24 2Impax Laboratories
25 2Indoco Remedies Limited
26 2Intas Pharmaceuticals
27 2JAMP PHARMA
28 2Laboratoire Riva
29 2Laboratorio Eczane Pharma
30 1Laboratorios Lafage
31 2MANTRA PHARMA INC
32 2MARCAN PHARMACEUTICALS INC
33 2MINT PHARMACEUTICALS INC
34 2Macleods Pharmaceuticals Limited
35 2Medichem S.A
36 2Micro Labs Limited
37 2Natco Pharma (Canada) Inc
38 4Nora Pharma
39 2PRO DOC LIMITEE
40 2Pfizer Inc
41 1Prinston
42 5Pulse Pharmaceuticals
43 2SANIS HEALTH INC
44 2SIVEM PHARMACEUTICALS ULC
45 4Sandoz B2B
46 1ScieGen Pharmaceuticals
47 2Sigmapharm Laboratories, LLC
48 1Stivaph Healthcare
49 6Sun Pharmaceutical Industries Limited
50 2Sunshine Lake Pharma
51 2Tecnimede
52 3Teva Pharmaceutical Industries
53 2Titan Laboratories
54 4Torrent Pharmaceuticals Limited
55 2Viatris
56 2Wanbang Biopharmaceuticals
57 2Zentiva
58 1Zhejiang Yongning Pharmaceutical Co., Lt
59 2Zydus Lifesciences
60 2Zydus Pharmaceuticals
01 11Antic-calc Tablet, Film Coated
02 1Apixaban 2,5Mg 10 Units Oral Use
03 1Apixaban 2,5Mg 20 Joined' Oral Use
04 1Apixaban 2,5Mg 60 Units Oral Use
05 1Apixaban 5Mg 28 Combined Oral Use
06 1Apixaban 5Mg 60 Units Oral Use
07 2Coated Tablet
08 1Each Coated Tablet
09 14FCT
10 2FILM COATED PILL
11 1FOR SUSPENSION;ORAL
12 10Film Coated Tablet
13 2Film Coated Tablet
14 7Film-Coated Tablets
15 2Oral Solid Dosage Form
16 1SUSPENSION;ORAL
17 4TAB
18 40TABLET
19 1TABLET, FOR SUSPENSION;ORAL
20 6TABLET; ORAL
21 35TABLET;ORAL
22 20Tablet
23 2Tablets
24 3tablet
25 5Blank
01 16DISCN
02 4EU Dossier Readiness-Q4 2018
03 16Generic
04 2Lead Market Dossiers- Filed
05 2Originator
06 40Prescription
07 14RX
08 80Blank
01 2ACH-APIXABAN
02 2AG-APIXABAN
03 41APIXABAN
04 1APIXABAN 2,5 DRL
05 1APIXABAN 5 DRL
06 2APO-APIXABAN
07 2AURO-APIXABAN
08 2Apixaban
09 1Apixaban 2,5 Accord
10 1Apixaban 5 Accord
11 2BIO-APIXABAN
12 1Deksel CD
13 10ELIQUIS
14 1ELIQUIS SPRINKLE
15 1EPLIPIX 2,5
16 1EPLIPIX 5
17 5Eliqs
18 26Eliquis
19 1Eliquis 2.5 mg
20 1Eliquis 5 mg
21 2Emboxan
22 1Fibranix 2,5
23 1Fibranix 5
24 1INNOKLOD 2,5
25 1INNOKLOD 5
26 2JAMP APIXABAN
27 2M-APIXABAN
28 2MAR-APIXABAN
29 2MINT-APIXABAN
30 2NAT-APIXABAN
31 2NRA-APIXABAN
32 2NRA-APIXABAN TABLETS
33 1PIXECLOT 2.5 mg
34 1PIXECLOT 5 mg
35 2PRO-APIXABAN
36 2RIVA APIXABAN
37 1Regrenor
38 2SANDOZ APIXABAN SDZ
39 2TARO-APIXABAN
40 2TEVA-APIXABAN
41 2Thromboxan
42 2Xanza
43 1Xarpix 2,5
44 1Xarpix 5
45 1Zyquis 2.5
46 1Zyquis 5
47 29Blank
01 2Argentina
02 8Australia
03 40Canada
04 2China
05 2Czech Republic
06 6Germany
07 1Guatemala
08 18India
09 5Italy
10 11Norway
11 4Portugal
12 18South Africa
13 4Spain
14 2Sweden
15 7Switzerland
16 44USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET; ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number : 210082
Regulatory Info :
Registration Country : USA
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Regulatory Info : DISCN
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2021-07-26
Application Number : 209845
Regulatory Info : DISCN
Registration Country : USA
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info :
Registration Country : India
Brand Name : Apixaban
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Regulatory Info : DISCN
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2021-07-26
Application Number : 209845
Regulatory Info : DISCN
Registration Country : USA
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info :
Registration Country : India
Brand Name : Apixaban
Dosage Form : Tablet
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : ELIQUIS
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2012-12-28
Application Number : 202155
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ELIQUIS
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2012-12-28
Application Number : 202155
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ELIQUIS
Dosage Form : TABLET, FOR SUSPENSION;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 2025-04-17
Application Number : 202155
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2025-02-14
Application Number : 209810
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2025-02-14
Application Number : 209810
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2020-09-11
Application Number : 209898
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2020-09-11
Application Number : 209898
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 2.GMG
Packaging :
Approval Date :
Application Number : 209944
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 209944
Regulatory Info :
Registration Country : USA
